» Articles » PMID: 3709632

The Effect of Prednisone and Hydrocortisone on the Plasma Protein Binding of Prednisolone in Man

Overview
Specialty Pharmacology
Date 1986 Jan 1
PMID 3709632
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The protein binding of prednisolone was studied in plasma obtained from healthy volunteers in the presence of added amounts of prednisone and hydrocortisone. The plasma protein binding was determined using in vitro equilibrium dialysis for 16 h at 37 degrees C against isotonic Krebs-Ringer buffer using radioactive prednisolone. Prednisone appeared to have no effect on prednisolone binding. This surprising result was observed even when prednisone concentrations were more than 35 fold greater than prednisolone concentrations. In contrast, a marked competition between hydrocortisone and prednisolone was observed. These binding data were fit using a nonlinear least squares regression computer program and the capacity and affinity constants for the binding of prednisolone to transcortin and albumin were estimated including the competition for binding sites between prednisolone and hydrocortisone. The results from these studies compare favorably with recent parameter calculations, and our previous work where differences in binding were noted between cushingoid and noncushingoid patients.

Citing Articles

A pharmacokinetic/pharmacodynamic approach to predict total prednisolone concentrations in human plasma.

Xu J, Winkler J, Derendorf H J Pharmacokinet Pharmacodyn. 2007; 34(3):355-72.

PMID: 17318442 DOI: 10.1007/s10928-007-9050-8.


Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone.

ROLLIN C, Chosidow O, Diquet B, Dutreuil C, Herson S, Revuz J Eur J Clin Pharmacol. 1993; 44(4):395-9.

PMID: 8513854 DOI: 10.1007/BF00316481.


The macromolecular binding of prednisone in plasma of healthy volunteers including pregnant women and oral contraceptive users.

Gustavson L, Benet L J Pharmacokinet Biopharm. 1985; 13(6):561-9.

PMID: 3834071 DOI: 10.1007/BF01058901.


Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor....

Bosanquet A Cancer Chemother Pharmacol. 1989; 23(4):197-207.

PMID: 2466580 DOI: 10.1007/BF00451642.


Clinical pharmacokinetics of prednisone and prednisolone.

Frey B, Frey F Clin Pharmacokinet. 1990; 19(2):126-46.

PMID: 2199128 DOI: 10.2165/00003088-199019020-00003.

References
1.
Legler U, Frey F, Benet L . Prednisolone clearance at steady state in man. J Clin Endocrinol Metab. 1982; 55(4):762-7. DOI: 10.1210/jcem-55-4-762. View

2.
CHEN Jr P, MILLS I, Bartter F . Ultrafiltration studies of steroid-protein binding. J Endocrinol. 1961; 23:129-37. DOI: 10.1677/joe.0.0230129. View

3.
Tozer T, Gambertoglio J, Furst D, Avery D, Holford N . Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humans. J Pharm Sci. 1983; 72(12):1442-6. DOI: 10.1002/jps.2600721218. View

4.
Lewis G, Jusko W, Graves L, BURKE C . Prednisone side-effects and serum-protein levels. A collaborative study. Lancet. 1971; 2(7728):778-80. DOI: 10.1016/s0140-6736(71)92738-3. View

5.
Frey F, Frey B, Benet L . Liquid-chromatographic measurement of endogenous and exogenous glucocorticoids in plasma. Clin Chem. 1979; 25(11):1944-7. View